Danish pharma giant Novo to use Anthropic's Claude to advance AI drug discovery
6 hours ago
- Novo Nordisk has partnered with Anthropic to use AI for accelerating drug development.
- Anthropic's AI models will enhance scientific reasoning and productivity in Novo's R&D.
- The CEO of Anthropic claims AI could compress a century of biomedical breakthroughs into a decade.
- Novo is already using OpenAI's science GPT-Rosalind and has founded a Danish AI supercomputer center.
- Anthropic is also collaborating with Bristol Myers Squibb to deploy AI across multiple corporate functions.